Call Options

18 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 12, 2022

BUY
$42.05 - $47.77 $6.93 Million - $7.87 Million
164,800 Added 194.8%
249,400 $807,000
Q1 2022

May 12, 2022

BUY
$40.23 - $47.74 $1.49 Million - $1.77 Million
37,100 Added 78.11%
84,600 $89,000
Q4 2021

Feb 14, 2022

BUY
$38.88 - $45.31 $159,408 - $185,771
4,100 Added 9.45%
47,500 $43,000
Q3 2021

Nov 10, 2021

SELL
$38.79 - $43.16 $818,469 - $910,675
-21,100 Reduced 32.71%
43,400 $12,000
Q2 2021

Aug 11, 2021

BUY
$36.52 - $41.46 $1.38 Million - $1.57 Million
37,900 Added 142.48%
64,500 $131,000
Q1 2021

May 14, 2021

BUY
$34.27 - $40.01 $34,270 - $40,010
1,000 Added 3.91%
26,600 $7,000
Q4 2020

Feb 16, 2021

BUY
$34.07 - $39.94 $265,746 - $311,532
7,800 Added 43.82%
25,600 $11,000
Q3 2020

Nov 13, 2020

SELL
$38.11 - $42.99 $697,413 - $786,717
-18,300 Reduced 50.69%
17,800 $4,000
Q2 2020

Aug 10, 2020

BUY
$37.87 - $43.58 $863,435 - $993,624
22,800 Added 171.43%
36,100 $32,000
Q1 2020

May 08, 2020

SELL
$32.47 - $48.83 $2.06 Million - $3.1 Million
-63,500 Reduced 82.68%
13,300 $16,000
Q4 2019

Feb 11, 2020

BUY
$42.0 - $48.25 $777,000 - $892,625
18,500 Added 31.73%
76,800 $318,000
Q3 2019

Nov 12, 2019

BUY
$40.46 - $43.52 $1.89 Million - $2.04 Million
46,800 Added 406.96%
58,300 $106,000
Q2 2019

Aug 14, 2019

SELL
$39.4 - $42.7 $55,160 - $59,780
-1,400 Reduced 10.85%
11,500 $14,000
Q1 2019

May 10, 2019

SELL
$38.57 - $42.69 $34,713 - $38,421
-900 Reduced 6.52%
12,900 $14,000
Q4 2018

Feb 12, 2019

SELL
$37.8 - $42.69 $37,800 - $42,690
-1,000 Reduced 6.76%
13,800 $9,000
Q3 2018

Nov 09, 2018

SELL
$39.75 - $42.69 $604,200 - $648,888
-15,200 Reduced 50.67%
14,800 $24,000
Q2 2018

Aug 13, 2018

SELL
$39.61 - $42.76 $122,791 - $132,556
-3,100 Reduced 9.37%
30,000 $51,000
Q1 2018

May 11, 2018

BUY
$36.18 - $40.15 $1.2 Million - $1.33 Million
33,100 New
33,100 $56,000

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.2B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.